Evidence map›Paper›PMID 38501406›Full record

Trial reportNan fang yi ke da xue xue bao = Journal of Southern Medical University2024

[Efficacy of navel application of Jianpiwenyang Gel for chronic diarrhea of spleen and stomach weakness type: a randomized controlled trial and analysis of the mechanism].

Y Cui, D Wang, D Xie, H Wang, R Xu, X Tang, Y Zhang

Abstract readRandomized Controlled TrialEnglish Abstract
PubMed Full text at PMC Publisher
In one paragraph

Trial report in Nan fang yi ke da xue xue bao = Journal of Southern Medical University, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Y CuiDepartment of Traditional Chinese Medicine of the Sixth Clinical Center, Chinese PLA General Hospital, Beijing 100853, China.
D WangSecond Outpatient Department, Aerospace Center Hospital, Beijing 100049, China.
D XieDepartment of Ultrasound of the First Clinical Center, Chinese PLA General Hospital, Beijing 100853, China.
H WangDepartment of Traditional Chinese Medicine of the Sixth Clinical Center, Chinese PLA General Hospital, Beijing 100853, China.
R XuDepartment of Traditional Chinese Medicine of the Sixth Clinical Center, Chinese PLA General Hospital, Beijing 100853, China.
X TangDepartment of Traditional Chinese Medicine of the Sixth Clinical Center, Chinese PLA General Hospital, Beijing 100853, China.
Y ZhangDepartment of Traditional Chinese Medicine of the Sixth Clinical Center, Chinese PLA General Hospital, Beijing 100853, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo investigate the efficacy of

methodsEighty patients with chronic diarrhea of spleen and stomach weakness type were randomized into two groups for interventions with lifestyle adjustment and treatment with bifid triple viable capsules (control group,

resultsIn both groups, gastrointestinal symptom rating scale (GSRS), Bristol Scale and TCM syndrome scores significantly improved after the treatments (

conclusionSSWYG can significantly improve clinical symptoms of chronic diarrhea possibly by regulating the TNF and IL-17 as well as other pathways

Indexed as

Drugs, Chinese HerbalSpleenCaspase 3DiarrheaHumansInterleukin-17Molecular Docking SimulationStomachCaspase 3Drugs, Chinese HerbalInterleukin-17chronic diarrheaJianpiwenyang Gelmolecular dockingnavel therapynetwork pharmacology

Identifiers

PMID38501406
PMCPMC10954536

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.